VS3 Medical Stent System
Symptomatic Venous Sinus Stenosis (VSS)
First-in-HumanActive
Key Facts
About VS3 Medical
VS3 Medical is an early-stage neurovascular device company targeting the underserved market of symptomatic venous sinus stenosis. Founded in 2022 and backed by premier venture capital firms, the company has advanced its novel stent system into first-in-human clinical studies, with initial cases presented at a major neurointerventional conference in early 2026. The company is led by an experienced team with medical device and neurovascular expertise and is currently in a pivotal clinical development phase with its sole, focused program.
View full company profile